Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy

American Journal of Hematology

Volumn 92, Issue 9, 2017, Pages 851-857

  Bialkowski, Walter ^a   Kiss, Joseph E ^b   Wright, David J ^c   Cable, Ritchard ^d   Birch, Rebecca ^c   D'Andrea, Pam ^b   Bryant, Barbara J ^e   Spencer, Bryan R ^d   Mast, Alan E ^a,f  

^a BLOOD RESEARCH INSTITUTE   (United States)

^b INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^c WESTAT   (United States)

^d AMERICAN RED CROSS BLOOD SERVICES   (United States)

^e University of Texas Medical Branch School of Medicine   (United States)

^f MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CIMETIDINE; ESOMEPRAZOLE; FERRITIN; FERROUS GLUCONATE; HEMOGLOBIN; IRON; LANSOPRAZOLE; PLACEBO; FERROUS ION;

ADULT; ARTICLE; BLOOD DONOR; BODY COMPOSITION; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DOSE COMPARISON; ERYTHROCYTE; FEMALE; HUMAN; IRON DEFICIENCY; IRON STORAGE; IRON THERAPY; LONGITUDINAL STUDY; LOW DRUG DOSE; MALE; PHLEBOTOMY; POPULATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; TOTAL BODY IRON; ADVERSE EFFECTS; ANEMIA, IRON-DEFICIENCY; BLOOD; POSTOPERATIVE COMPLICATIONS;

ANEMIA, IRON-DEFICIENCY; FEMALE; FERROUS COMPOUNDS; HUMANS; IRON; MALE; PHLEBOTOMY; POSTOPERATIVE COMPLICATIONS;

EID: 85020448278     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24784     Document Type: Article

References (33)

1. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: analysis of enrollment data from the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2011;51(3):511–522.
2. Salvin HE, Pasricha SR, Marks DC, Speedy J. Iron deficiency in blood donors: a national cross-sectional study. Transfusion. 2014;54(10):2434–2444.
3. Baart AM, van Noord PA, Vergouwe Y, et al. High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin. Transfusion. 2013;53(8):1670–1677.
4. Lee CK, Wong HK, Hong J, Leung JN, Tsoi WC, Lin CK. A study of the predonation hemoglobin and iron status among Hong Kong Chinese blood donors. Transfusion. 2013;53(2):322–327.
5. Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;373(5):485–486.
6. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117383
7. Piperno A, Girelli D, Nemeth E, et al. Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis. Blood. 2007;110(12):4096–4100.
8. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood. 2007;110(6):2182–2189.
9. Moretti D, Goede JS, Zeder C, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015;126(17):1981–1989.
10. Schrier SL. So you know how to treat iron deficiency anemia. Blood. 2015;126(17):1971
11. Minihane AM, Fairweather-Tait SJ. Effect of calcium supplementation on daily nonheme-iron absorption and long-term iron status. Am J Clin Nutr. 1998;68(1):96–102.
12. Benkhedda K, L'abbe MR, Cockell KA. Effect of calcium on iron absorption in women with marginal iron status. Br J Nutr. 2010;103(5):742–748.
13. Hutchinson C, Geissler CA, Powell JJ, Bomford A. Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut. 2007;56(9):1291–1295.
14. Bialkowski W, Bryant BJ, Schlumpf KS, et al. The strategies to reduce iron deficiency in blood donors randomized trial: design, enrolment and early retention. Vox Sang. 2015;108(2):178–185.
15. Mast AE, Bialkowski W, Bryant BJ, et al. A randomized, blinded, placebo-controlled trial of education and iron supplementation for mitigation of iron deficiency in regular blood donors. Transfusion. 2016;56(6 Pt 2):1588–1597.
16. Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–232.
17. Bernhart FW, Skeggs L. The iron content of crystalline human hemoglobin. J Biol Chem. 1943;147:19–22.
18. Chaplin H, Jr., Mollison PL, Vetter H. The body/venous hematocrit ratio: its constancy over a wide hematocrit range. J Clin Invest. 1953;32(12):1309–1316.
19. Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359–3364.
20. Pfeiffer CM, Cook JD, Mei Z, Cogswell ME, Looker AC, Lacher DA. Evaluation of an automated soluble transferrin receptor (sTfR) assay on the Roche Hitachi analyzer and its comparison to two ELISA assays. Clin Chim Acta. 2007;382(1–2):112–116.
21. Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood. 1990;75(9):1870–1876.
22. Cable RG, Glynn SA, Kiss JE, et al. Iron deficiency in blood donors: the REDS-II Donor Iron Status Evaluation (RISE) study. Transfusion. 2012;52(4):702–711.
23. Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005;118(10):1142–1147.
24. Kiss JE, Brambilla D, Glynn SA, et al. Oral iron supplementation after blood donation: a randomized clinical trial. JAMA. 2015;313(6):575–583.
25. Schotten N, Pasker-de Jong PC, Moretti D, et al. The donation interval of 56 days requires extension to 180 days for whole blood donors to recover from changes in iron metabolism. Blood. 2016;128(17):2185–2188.
26. Mast AE, Lee TH, Schlumpf KS, et al. The impact of HFE mutations on haemoglobin and iron status in individuals experiencing repeated iron loss through blood donation. Br J Haematol. 2012;156(3):388–401.
27. Kantor ED, Rehm CD, Haas JS, Chan AT, Giovannucci EL. Trends in prescription drug use among adults in the United States from 1999–2012. JAMA. 2015;314(17):1818–1831.
28. Brittenham G. Disorders of iron homeostasis. In: Hoffman R, Benz Jr. EJ, Silberstein LE, Heslop H, Weitz J, Anastasi J, eds. Hematology: Basic Principles and Practice. 6th ed. Elsevier; 2013:437–449.
29. Girelli D, Trombini P, Busti F, et al. A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica. 2011;96(4):500–506.
30. Cook JD, Reddy MB. Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr. 1995;62(1):117–120.
31. Bryant BJ, Yau YY, Arceo SM, Daniel-Johnson J, Hopkins JA, Leitman SF. Iron replacement therapy in the routine management of blood donors. Transfusion. 2012;52(7):1566–1575.
32. Radtke H, Tegtmeier J, Rocker L, Salama A, Kiesewetter H. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion. 2004;44(10):1427–1432.
33. Makrides M, Crowther CA, Gibson RA, Gibson RS, Skeaff CM. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr. 2003;78(1):145–153.